BUDZ WEED, INC.
Services-Commercial Physical & Biological Research · OTC · SEC CIK 1393772 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-49.2%
TTM EPS YoY-33.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-216.0%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets301.6%
Debt / equity—
Current ratio0.01x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.21x
Accruals ratio-170.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| SG&A expense | $55,819 | $74,726 | $67,833 | $622,258 | $58,519 | $64,052 | $383,268 | $64,422 |
| Operating income | -$83,390 | -$90,911 | -$163,955 | -$726,874 | -$66,897 | -$94,045 | -$434,737 | -$127,462 |
| Interest expense | $13,629 | $13,221 | — | — | $7,016 | $13,571 | $5,718 | -$4,493 |
| Pretax income | -$97,019 | -$104,132 | -$175,256 | -$750,188 | -$73,913 | -$107,616 | -$440,455 | -$133,224 |
| Income tax | $0 | $0 | $0 | $0 | $33 | $0 | $0 | $0 |
| Net income | -$97,019 | -$104,132 | -$175,256 | -$750,188 | -$73,946 | -$107,616 | -$440,455 | -$133,224 |
| EBITDA | -$77,966 | -$85,476 | -$158,333 | -$728,943 | -$58,712 | -$88,424 | -$429,115 | -$121,840 |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | — | -0.00 | -0.00 | -0.00 | — |
| Weighted avg. shares (diluted) | 148.45M | 148.31M | 147.51M | — | 135.93M | 135.93M | 132.43M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $663 | $1,066 | $1,795 | $33,130 | $400 | $5,350 | $3,142 | $159,355 |
| Current assets | $19,683 | $7,631 | $12,365 | $47,705 | $10,933 | $18,482 | $35,658 | $189,891 |
| PP&E, net | $461,936 | $466,711 | $471,496 | $476,467 | $481,439 | $486,411 | $491,382 | $496,354 |
| Intangibles | $29,033 | $29,683 | $30,333 | $30,983 | $31,633 | — | — | $33,583 |
| Total assets | $510,652 | $504,025 | $515,713 | $559,906 | $532,267 | $548,906 | $575,128 | $738,366 |
| Current liabilities | $1.54M | $1.44M | $1.35M | $1.25M | $1.05M | $996,833 | $921,364 | $959,372 |
| Total liabilities | $1.54M | $1.44M | $1.35M | $1.25M | $1.05M | $996,833 | $921,364 | $959,372 |
| Shareholders' equity | -$1.03M | -$939,171 | -$837,527 | -$688,361 | -$519,079 | -$447,927 | -$346,236 | -$221,006 |
| Shares outstanding | 148.53M | 148.31M | 148.31M | 148.53M | 135.93M | 135.93M | 135.93M | 125.43M |
| Cash flow statement | ||||||||
| Operating cash flow | -$40,403 | -$18,729 | -$57,737 | -$119,665 | -$4,952 | $1,319 | -$71,838 | -$136,370 |
| Financing cash flow | $40,000 | $18,000 | $29,200 | $152,403 | $0 | $2,000 | -$84,300 | $290,269 |
| Depreciation & amortization | $5,424 | $5,435 | $5,622 | -$2,069 | $8,185 | $5,621 | $5,622 | $5,622 |
| Stock-based compensation | $0 | $0 | $0 | $500,000 | $0 | $0 | $300,000 | — |
Free plan shows the latest 8 periods; Pro shows all 46 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.